Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
222 Leser
Artikel bewerten:
(0)

FDA Warns Consumers of Botulism Risk in La Ruche Tapenade, Spreadable Tomato Paste

Severe botulism cases reported in France linked to these products

SILVER SPRING, Md., Sept. 10, 2011 /PRNewswire-USNewswire/ -- The FDA is warning consumers not to eat tapenade or spreadable dried tomato paste manufactured by the French food company La Ruche. French health authorities have reported an outbreak of botulism in France linked to the company's products sold under the brand names "Les delices de Marie-Claire," "Terre de Mistral" and Les Secrets d'Anais." Eight adults are currently suffering from respiratory failure as a result of eating foods containing the neurotoxin produced by Clostridium botulinum.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO )

French authorities have ordered production halted at the company's facility in France and have directed that all products sold under those brand names be recalled.

Products of the brands noted above are considered a severe threat to public health and should not be eaten. If consumers purchased any of these products, either while traveling in France or online, throw them away. If consumers have recently eaten any of these products and have symptoms of botulism, see your healthcare provider immediately.

At this time, the FDA has no indication that any of these products has been imported into the U.S. The FDA also has no information that this outbreak has affected anyone in the U.S. FDA has increased its monitoring of shipments from this area of the world and has issued a bulletin to its Field Offices today to be vigilant in this area.

Botulism can result in death due to respiratory failure. The classic symptoms of botulism include double vision, blurred vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, and muscle weakness. Infants with botulism appear lethargic, feed poorly, are constipated, and have a weak cry and poor muscle tone. These are all symptoms of the muscle paralysis caused by the bacterial toxin. If untreated, these symptoms may progress to cause paralysis of the respiratory muscles, arms, legs, and trunk. In foodborne botulism, symptoms generally begin 18 to 36 hours after eating a contaminated food, but they can occur as early as 6 hours or as late as 10 days.

For more information:

  • FDA What You Need to Know About Foodborne Illness-Causing Organisms in the U.S.
    http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm103263.htm
  • FoodSafety. Gov - Botulism
    http://www.foodsafety.gov/poisoning/causes/bacteriaviruses/botulism/
  • CDC - Botulism
    http://www.cdc.gov/nczved/divisions/dfbmd/diseases/botulism/

FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The Agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Siobhan DeLancey, 202-510-4177, siobhan.delancey@fda.hhs.gov
Consumer Inquiries: 1-888-INFO-FDA

SOURCE U.S. Food and Drug Administration

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.